Synthetic Cannabinoids

Subcategory T40.7, Poisoning by, adverse effect of and underdosing of cannabis (derivatives), has been expanded to differentiate poisoning, adverse effect of and underdosing of cannabis from synthetic cannabinoids. The two new sub-subcategories are:T40.71, Poisoning by, adverse effect of and underdosing of cannabis (derivatives)  T40.72, Poisoning by, adverse effect of and underdosing of synthetic cannabinoids Corresponding codes have been created at each subcategory for poisoning accidental (unintentional), poisoning intentional self-harm, poisoning assault, and poisoning undetermined, as well as for adverse effect and underdosing. Appropriate seventh characters are required for initial encounter, subsequent encounter and sequela. ...

Subscribe or sign in to view the full article.

articles:    previous index next
Note:  The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.

Article Overview

This article is about an ICD-10-CM update that distinguishes cannabis (derivatives) from synthetic cannabinoids within the poisoning, adverse effect, and underdosing category structure. It is relevant for coding professionals, compliance teams, and clinicians who need to understand the scope of the updated classification and the general context of synthetic cannabinoid-related harm. The article also provides a non-technical overview of synthetic cannabinoids, including their illicit nature and associated health risks, to help readers recognize the clinical and coding relevance of these substances.

Why This Topic Matters

The update affects how substance-related encounters are classified in ICD-10-CM and helps support more accurate capture of cannabis versus synthetic cannabinoid cases. It also highlights why these cases may appear in emergency, behavioral health, toxicology, and general medical settings.

Article Sections

  1. ICD-10-CM classification update

    Overview of the coding update that separates cannabis-related cases from synthetic cannabinoid-related cases within the poisoning framework.

  2. Clinical overview of synthetic cannabinoids

    General background on synthetic cannabinoids, including what they are and the broad health impacts associated with exposure and use.

What You Will Learn

  • How the ICD-10-CM structure was updated to distinguish cannabis from synthetic cannabinoids
  • What general substance-related encounter categories are referenced in the update
  • The broad clinical context and health risks associated with synthetic cannabinoids
  • Why this topic matters for substance-related diagnosis coding and documentation review

Who Should Read This

  • Medical coders
  • Coding auditors
  • Compliance staff
  • Clinical documentation staff
  • Emergency department staff
  • Behavioral health and toxicology reviewers

Codes Discussed

Code Ranges Discussed

  • ICD-10-CM: T40.71-T40.72

Subscribe or sign in to view the full article.

  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?